Safety Pharmacology Society 2023 Annual Meeting, Sept. 18-21, Brussels, Belgium

Join CBSET and our partner CILcare at the Safety Pharmacology Society 2023 Annual Meeting, September 18-21, in Brussels, Belgium. We will be exhibiting in booth #506.

CBSET Study Director, Donald Hodges, will be presenting "Swine, the Other Tox Species (or Beyond Medical Device Testing)" as part of a partner session with Dr. Michael Stonerook (AmplifyBio) and Dr. Dany Salvail (IPS Therapeutique) that will present the benefits and insights obtained from rodent and non-rodent species in recent experiments: Maximizing Insights from Animal Studies in the Context of Rising Costs and Shortages - September 19, 2023, 12:30 - 1:30 PM, in Meeting Studio 212.

Space is limited. Register for this session to save your seat! https://hubs.ly/Q020mcFH0

The Safety Pharmacology Society is working to bring a dynamic program featuring topics addressing the development and safe medical use of biologically active molecular entities.

Please contact us to schedule a meeting at the SPS Annual Meeting or to learn more about how we can help with your in vitro, ex vivo, or in vivo studies.




    Related Services and Publications:

    HEAR THIS! Potential Therapeutics for COVID-19 Should Be Tested for Auditory Safety

    by Wahid Awad, PhD, Chief Business Officer, CILcare and Michael Naimark, Director of Business Development, CBSET, Inc.

    World Pharma Today, August 24, 2020


    wpt-coverAuditory Therapy, Ototoxicity, and GLP Compliance: Will the promising market for ear disorder treatments follow ophthalmology’s dramatic growth curve?

    by Michael Naimark, Director of Business Development, CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, founder and the Chief Development Officer, CILcare

    Published in World Pharma Today, November 1, 2017